BeStock  

Medpace MEDP

US equityMarket cap rank #1009Diagnostics & Research
$610.54 −$23.44 (-3.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $605.49 -0.83%
Open$632.09
Prev close$633.98
Day range$606.73 – $633.87
Volume236.8K
Market cap$17.08B
P/E (TTM)33.9
Dividend yield–

Earnings

Average move on report day±14.5%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+54.7%
Worst reaction-22.6%

Stock move on the day after each report

+12.3%2023/Q4+8.2%2024/Q1-18.3%2024/Q2-7.5%2024/Q3-7.5%2024/Q4-2.3%2025/Q1+54.7%2025/Q2+9.1%2025/Q3-15.9%2025/Q4-22.6%2026/Q1+14.7%2026/Q2-1.3%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q321 Oct 2026After Market±13.8%-1.29%Within range
2026/Q222 Jul 2026After Market±15.3%+14.71%Within range
2026/Q122 Apr 2026After Market±14.7%-22.63%Bigger than priced
2025/Q49 Feb 2026After Market±11.6%-15.90%Bigger than priced
2025/Q322 Oct 2025After Market±14.0%+9.12%Within range
2025/Q221 Jul 2025After Market±13.7%+54.67%Bigger than priced
2025/Q121 Apr 2025After Market±15.8%-2.32%Within range
2024/Q410 Feb 2025After Market±11.6%-7.52%Within range
2024/Q321 Oct 2024After Market±15.8%-7.47%Within range
2024/Q222 Jul 2024After Market±13.0%-18.27%Bigger than priced
2024/Q122 Apr 2024After Market±13.4%+8.21%Within range
2023/Q412 Feb 2024After Market±12.2%+12.30%Bigger than priced
2023/Q224 Jul 2023After Market±10.8%+3.91%Within range
2023/Q124 Apr 2023After Market±12.3%+11.22%Within range
2022/Q413 Feb 2023After Market±13.1%-5.12%Within range
2022/Q324 Oct 2022After Market±14.6%+37.71%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$716.00M+8.5% YoY
Operating profit$165.54M+16.7% YoY
Net profit$137.46M+23.7% YoY
Diluted EPS$4.84+25.4% YoY
Free cash flow$196.44M-16.6% YoY
Operating cash flow$216.60M

Revenue, last 8 quarters

$536.6MDec '24$558.6MMar '25$603.3MJun '25$659.9MSep '25$708.5MDec '25$706.6MMar '26$707.3MJun '26$716.0MSep '26

Net profit, last 8 quarters

$117.0MDec '24$114.6MMar '25$90.3MJun '25$111.1MSep '25$135.1MDec '25$123.9MMar '26$121.4MJun '26$137.5MSep '26

Profitability & balance sheet

Gross margin29.1%
Operating margin21.4%
Net margin18.2%
Return on equity117.9%
Return on assets25.5%
Return on invested capital90.6%
Current ratio0.83
Liabilities / assets74.6%
Cash & investments$705.32M
Total debt$146.04M
Net cash (debt)$559.27M
Free cash flow / sales23.5%

Discussion

No comments yet — be the first to weigh in on MEDP.

Sign in to join the discussion.

Scroll to Top